Medaro Mining Terminates Yurchison Uranium Property Option Agreement
Medaro Mining (CSE: MEDA, OTC: MEDAF, FSE: 1ZY0) has announced the termination of its option agreement with Skyharbour Resources regarding the Yurchison uranium property.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Medaro Mining (CSE: MEDA, OTC: MEDAF, FSE: 1ZY0) has announced the termination of its option agreement with Skyharbour Resources regarding the Yurchison uranium property. The termination will be effective February 12, 2025. The original agreement was dated November 1, 2021.
Positive
- None.
Negative
- Loss of potential uranium asset through option agreement termination
- Reduction in company's property portfolio
Details
News Market Reaction – MEDAF
The recorded move for MEDAF in the trading session of this news was +2.53%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Vancouver, British Columbia--(Newsfile Corp. - January 14, 2025) - Medaro Mining Corp. (CSE: MEDA) (OTC Pink: MEDAF) (FSE: 1ZY0) ("Medaro" or the "Company") announces that it has terminated, effective February 12, 2025, its option agreement with Skyharbour Resources Ltd. ("Skyharbour") dated November 1, 2021, as amended, respecting the Yurchison uranium property.
On Behalf of the Board of Directors
Michael Mulberry
CEO & Director
About the Company
The Company is a lithium exploration company based in Vancouver, BC, and holds options over the Darlin, Rapide, Lac La Motte and CYR South lithium properties in Quebec. The Company owns the James Bay Pontax Project in Quebec. The Company is a party to a joint venture agreement that engages the Company in the development and commercialization of a new process to extract lithium from spodumene concentrate.
For more information, investors should review the Company's filings that are available at www.sedarplus.ca.
Contact Information
info@medaromining.com
778-837-7191
Neither Canadian Securities Exchange nor its regulation services provider accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/237201
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.